Table: Santen Pharm -2023/24 parent results

SANTEN PHARMACEUTICAL

09/05/2024 07:00

May 9 (Reuters)- 
          Santen Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended       Year ended       Year to       NEXT   
                Mar 31, 2024     Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST          YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales            195.24           196.59                                
                 (-0.7 pct)       (+3.0 pct)                              
  Operating         28.01            24.80                                
                 (+13.0 pct)     (+15.9 pct)                              
  Recurring         31.27            27.07                                
                 (+15.5 pct)     (+20.2 pct)                              
  Net               18.68         loss 59.38                              
  EPS             50.88 yen    loss 153.18 yen                            
  EPS Diluted     50.74 yen                                               
  Ann Div         33.00 yen       32.00 yen       34.00 yen               
  -Q2 Div         16.00 yen       16.00 yen       17.00 yen               
  -Q4 Div         17.00 yen       16.00 yen       17.00 yen               
  
  NOTE - Santen Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4536.T